Model
Edge
Lineage Cell Therapeutics
0001310683
Filing type
4
Filing date
Nov 21, 2024
Updated
Nov 22, 2024 ยท 7:00 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership